Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lazzari

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|May 1, 1990
Ketanserin in chronic treatment of hypertension in type 2 diabetes mellitusR Fogari, A Zoppi, C Pasotti, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1995
Ketanserin effects on insulin sensitivity in nonobese, nondiabetic hypertensive patients: an evaluation by the euglycemic-hyperinsulinemic clamp techniqueR Fogari, A Zoppi, G Derosa, et al.
British Journal of Clinical Pharmacology|December 2, 1998
Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patientsR Fogari, A Zoppi, L Corradi, et al.
American Journal of Hypertension|January 1, 1993
Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patternsR Fogari, A Zoppi, G D Malamani, et al.
American Journal of Hypertension|September 1, 1994
Urinary albumin excretion and nocturnal blood pressure in hypertensive patients with type II diabetes mellitusR Fogari, A Zoppi, G D Malamani, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|March 1, 1987
[When and why a celiac patient could be subjected to surgical intervention]R Lazzari, A Collina, E A Marino, et al.
Diabetes, Obesity & Metabolism|November 15, 2011
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitusR Fogari, A Zoppi, P Maffioli, et al.
Journal of Human Hypertension|February 1, 1995
Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non-insulin-dependent diabetes mellitus and impaired renal functionR Fogari, A Zoppi, C Pasotti, et al.
Journal of Human Hypertension|February 3, 1999
Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal functionR Fogari, A Zoppi, L Corradi, et al.
Journal of Cardiovascular Pharmacology|October 22, 1998
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patientsR Fogari, A Zoppi, P Lazzari, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Clinical Pharmacology, Therapy, and Toxicology|May 1, 1990
Ketanserin in chronic treatment of hypertension in type 2 diabetes mellitusR Fogari, A Zoppi, C Pasotti, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 1995
Ketanserin effects on insulin sensitivity in nonobese, nondiabetic hypertensive patients: an evaluation by the euglycemic-hyperinsulinemic clamp techniqueR Fogari, A Zoppi, G Derosa, et al.
British Journal of Clinical Pharmacology|December 2, 1998
Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patientsR Fogari, A Zoppi, L Corradi, et al.
American Journal of Hypertension|January 1, 1993
Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patternsR Fogari, A Zoppi, G D Malamani, et al.
American Journal of Hypertension|September 1, 1994
Urinary albumin excretion and nocturnal blood pressure in hypertensive patients with type II diabetes mellitusR Fogari, A Zoppi, G D Malamani, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|March 1, 1987
[When and why a celiac patient could be subjected to surgical intervention]R Lazzari, A Collina, E A Marino, et al.
Diabetes, Obesity & Metabolism|November 15, 2011
Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitusR Fogari, A Zoppi, P Maffioli, et al.
Journal of Human Hypertension|February 1, 1995
Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non-insulin-dependent diabetes mellitus and impaired renal functionR Fogari, A Zoppi, C Pasotti, et al.
Journal of Human Hypertension|February 3, 1999
Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal functionR Fogari, A Zoppi, L Corradi, et al.
Journal of Cardiovascular Pharmacology|October 22, 1998
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patientsR Fogari, A Zoppi, P Lazzari, et al.
Pageof 4